AngioDynamics, Inc. Sustainability Profile
AngioDynamics, Inc., a leading medical device company headquartered in the United States, has been at the forefront of innovative solutions since its founding in 1988. Specialising in the development of products for vascular access, oncology, and surgical procedures, AngioDynamics is renowned for its commitment to improving patient outcomes through advanced technology. With a strong presence in North America and expanding operations in international markets, the company offers a diverse range of core products, including catheter systems, ablation devices, and imaging solutions. AngioDynamics distinguishes itself through its focus on minimally invasive techniques, which enhance safety and efficacy in various medical applications. Recognised for its significant contributions to the healthcare industry, AngioDynamics continues to solidify its market position with a dedication to innovation and quality, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does AngioDynamics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AngioDynamics, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AngioDynamics, Inc.'s reported carbon emissions
AngioDynamics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that AngioDynamics may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the medical device industry, many companies are increasingly focusing on sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess AngioDynamics' position relative to its peers in terms of environmental responsibility.
How Carbon Intensive is AngioDynamics, Inc.'s Industry?
How Carbon Intensive is AngioDynamics, Inc.'s Location?
AngioDynamics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AngioDynamics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
